"Models, Immunological" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Theoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.
| Descriptor ID |
D018448
|
| MeSH Number(s) |
E05.599.395.500
|
| Concept/Terms |
Models, Immunological- Models, Immunological
- Immunologic Model
- Immunologic Models
- Models, Immunologic
- Model, Immunologic
- Immunological Models
- Immunological Model
- Model, Immunological
|
Below are MeSH descriptors whose meaning is more general than "Models, Immunological".
Below are MeSH descriptors whose meaning is more specific than "Models, Immunological".
This graph shows the total number of publications written about "Models, Immunological" by people in this website by year, and whether "Models, Immunological" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 4 | 4 |
| 2009 | 2 | 2 | 4 |
| 2010 | 1 | 2 | 3 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 4 | 4 |
| 2014 | 0 | 5 | 5 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Models, Immunological" by people in Profiles.
-
Fahl SP, Contreras AV, Verma A, Qiu X, Harly C, Radtke F, Z??iga-Pfl?cker JC, Murre C, Xue HH, Sen JM, Wiest DL. The E protein-TCF1 axis controls ?d T?cell development and effector fate. Cell Rep. 2021 02 02; 34(5):108716.
-
Moreno I, Franasiak JM. Endometrial microbiota-new player in town. Fertil Steril. 2017 07; 108(1):32-39.
-
Zhang X, Putoczki T, Markovic-Plese S. IL-11 in multiple sclerosis. Oncotarget. 2015 Oct 20; 6(32):32297-8.
-
Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014 Dec 19; 289(51):35237-45.
-
Fahl SP, Coffey F, Wiest DL. Origins of ?d T cell effector subsets: a riddle wrapped in an enigma. J Immunol. 2014 Nov 01; 193(9):4289-94.
-
Magee MS, Snook AE. Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer. Discov Med. 2014 Nov; 18(100):265-71.
-
Mishra A, Sullivan L, Caligiuri MA. Molecular pathways: interleukin-15 signaling in health and in cancer. Clin Cancer Res. 2014 Apr 15; 20(8):2044-50.
-
Coffey F, Lee SY, Buus TB, Lauritsen JP, Wong GW, Joachims ML, Thompson LF, Z??iga-Pfl?cker JC, Kappes DJ, Wiest DL. The TCR ligand-inducible expression of CD73 marks ?d lineage commitment and a metastable intermediate in effector specification. J Exp Med. 2014 Feb 10; 211(2):329-43.
-
Tyagi M, Bukrinsky M. Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication. Mol Med. 2012 Sep 25; 18:1096-108.
-
Kinoshita SM, Krutzik PO, Nolan GP. COP9 signalosome component JAB1/CSN5 is necessary for T cell signaling through LFA-1 and HIV-1 replication. PLoS One. 2012; 7(7):e41725.